ArticleCost effectiveness and resource allocation : C/E2008
Review of Australian health economic evaluation - 245 interventions: what can we say about cost effectiveness?
Article in Cost effectiveness and resource allocation : C/E, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.
- Costs and economic evaluations of Quality Improvement Collaboratives in healthcare: a systematic review.BMC health services research · 2020Pooled it
- Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic Review.American journal of preventive medicine · 2016Pooled it
- Cost-utility and cost consequence of a telehealth intervention targeting improvement in addictive eating for Australian adults (the TRACE program).Journal of public health (Oxford, England) · 2024Trial
- Mapping Kansas City cardiomyopathy, Seattle Angina, and minnesota living with heart failure to the MacNew-7D in patients with heart disease.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024Article
- Article
- Global Mapping of Interventions to Improve Quality of Life of Patients with Cancer: A Protocol for Literature Mining and Meta-Analysis.International journal of environmental research and public health · 2022Article
- Some reflections on the use of inappropriate comparators in CEA.Cost effectiveness and resource allocation : C/E · 2020Article
- Can cost-effectiveness results be combined into a coherent league table? Case study from one high-income country.Population health metrics · 2019Article
- Systematic Review of Health Economic Evaluation Studies Developed in Brazil from 1980 to 2013.Frontiers in public health · 2018Article
- Quality Assessment of Published Articles in Iranian Journals Related to Economic Evaluation in Health Care Programs Based on Drummond's Checklist: A Narrative Review.Iranian journal of medical sciences · 2017Review
- A cost analysis of somatostatin use in the prevention of pancreatic fistula after pancreatectomy.World journal of surgery · 2014Article
- Do economic evaluation studies inform effective healthcare resource allocation in Iran? A critical review of the literature.Cost effectiveness and resource allocation : C/E · 2014Review
- Recent economic evaluations of interventions to prevent cardiovascular disease by reducing sodium intake.Current atherosclerosis reports · 2013Review
- Calculating disability-adjusted-life-years lost (DALYs) in discrete-time.Cost effectiveness and resource allocation : C/E · 2013Article
- Nutrition economics - food as an ally of public health.The British journal of nutrition · 2013Article
- Comparison of outcomes and costs between laparoscopic distal pancreatectomy and open resection at a single center.Surgical endoscopy · 2012Article
- Article
- The cost-effectiveness of interventions designed to reduce sodium intake.Journal of hypertension · 2011Review
- A systematic review of economic evaluations of health and health-related interventions in Bangladesh.Cost effectiveness and resource allocation : C/E · 2011Article
- The use of economic evaluation in CAM: an introductory framework.BMC complementary and alternative medicine · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is an increasing body of published cost-utility analyses of health interventions which we sought to draw together to inform research and policy.
methodsTo achieve consistency in costing base and policy context, study scope was limited to Australian-based cost-effectiveness analyses. Through a comprehensive literature review we identified 245 health care interventions that met our study criteria.
resultsThe median cost-effectiveness ratio was A$18,100 (approximately US$13,000) per QALY/DALY/LY (quality adjusted life year gained or, disability adjusted life year averted or life year gained). Some modalities tended to perform worse, such as vaccinations and diagnostics (median cost/QALY $58,000 and $68,000 respectively), than others such as allied health, lifestyle, in-patient interventions (median cost/QALY/DALY/LY all at approximately A$9,000 approximately US$6,500). Interventions addressing some diseases such as diabetes and impaired glucose tolerance or alcohol and drug dependence tended to perform well (median cost/QALY/DALY/LY < A$3,700, < US$5,000). Interventions targeting younger persons < 25 years (median cost/QALY/DALY/LY < A$41,200) tended to perform less well than those targeting adults > 25 years (median cost/QALY/DALY/LY < A$16,000). However, there was also substantial variation in the cost effectiveness of individual interventions within and across all categories.
conclusionFor any given condition, modality or setting there are likely to be examples of interventions that are cost effective and cost ineffective. It will be important for decision makers to make decisions based on the individual merits of an intervention rather than rely on broad generalisations. Further evaluation is warranted to address gaps in the literature and to ensure that evaluations are performed in areas with greatest potential benefit.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.